Akers Biosciences Now Covered by Aegis (AKR)
Separately, analysts at Daniel Stewart & Co reiterated a “buy” rating on shares of Akers Biosciences in a research note on Wednesday, May 7th.
Shares of Akers Biosciences (LON:AKR) traded down 4.59% during mid-day trading on Monday, hitting GBX 260.00. The stock had a trading volume of 650 shares. Akers Biosciences has a 52 week low of GBX 156.00 and a 52 week high of GBX 325.00. The stock’s 50-day moving average is GBX 274.2 and its 200-day moving average is GBX 357.4.